Yoon S. Choi
Experienced in Spasmodic Dysphonia

Yoon S. Choi

Seoul, KR 
Experienced in Spasmodic Dysphonia
Seoul, KR 
OverviewLocationsClinical Research

Overview

Yoon Choi practices in Seoul, Republic of Korea. Mr. Choi is rated as an Experienced expert by MediFind in the treatment of Spasmodic Dysphonia. His top areas of expertise are Febrile Neutropenia, Omphalomesenteric Cyst, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Laryngectomy.

His clinical research consists of co-authoring 149 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Spasmodic Dysphonia.

Gender
Male

Locations

Seoul, Republic of Korea
Other Locations
Suwon, Republic of Korea
Daegu, Republic of Korea
Daejeon, Republic of Korea
Gyeonggi-do, Republic of Korea
Ulsan, Republic of Korea
Songnam, Republic of Korea
Gwangju, Republic of Korea
Gangneung, Republic of Korea
Gyeongsan-si, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
Enrollment Status: Completed
Publish Date: January 23, 2025
Intervention Type: Drug
Study Drugs: Zanubrutinib, Obinutuzumab
Study Phase: Phase 2
A Multi-center,Open, Longitudinal, Observational Study to Evaluate the Treatment Effectiveness and Safety of the Bortezomib-melphalan-prednisolone Regimen in Treatment-naïve Patients With Multiple Myeloma, Ineligible for Hematopoietic Transplantation
A Multi-center,Open, Longitudinal, Observational Study to Evaluate the Treatment Effectiveness and Safety of the Bortezomib-melphalan-prednisolone Regimen in Treatment-naïve Patients With Multiple Myeloma, Ineligible for Hematopoietic Transplantation
Enrollment Status: Completed
Publish Date: June 15, 2023
View 1 Less Clinical Trial

149 Total Publications

Leukemic Presentation of CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review.
Leukemic Presentation of CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review.
Journal: Annals of clinical and laboratory science
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Choi's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile